Scientists at St. Jude Children's Research Hospital, the American Society for Hematology (ASH) and the Munich Leukemia ...

Fox Chase researchers use 3D genomic testing to improve lymphoma and sarcoma diagnosis and treatment by revealing tumor cell ...

Initiative will create one of the world's largest multimodal cancer datasets and an integrated suite of AI models and tools to fuel precision medicine PharosAI brings together King's College London, ...

IRVINE, Calif., April 7, 2026 /PRNewswire/ -- Helio Genomics, Inc., an AI-powered TechBio company focused on early cancer detection, today announced the appointment of John Doyle to its Board of ...

Irvine, CA, USA, March 30th, 2026, FinanceWireHelio Genomics announces new HelioLiver access through Quest, expanding the ...

Even as therapies improve, a startling number of cancer patients are not getting genomic tests that could improve their chance of survival.

Multi-phase initiative will generate single cell and spatial data from over 20,000 samples across leading immuno-oncology laboratories to map the immune landscape of cancer and drive the next ...

DELFI Diagnostics, Inc., developer of innovative blood-based tests that leverage whole-genome cell-free DNA (cfDNA) assays for cancer detection and monitoring, today announced it will present five ...

For patients with challenging cancers like lymphoma and sarcoma, these 3D images dramatically change the way doctors diagnose and treat their disease.

Cancer genomics has revolutionised our understanding of tumour biology by deciphering the complex genetic alterations that underpin oncogenesis. Central to this field is the identification and ...